Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology

Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 years (19 months) for placebo (HR=0.23; p=0.008)7-year ...

Palantir: $150 Price Key For Bulls - Risk Of Major Bear Slide Rising

Palantir Technologies Inc. faces steep downside risk as extreme valuation meets weakening signals and insider selling. Click ...

Trump's Mortgage Plan Brought Rates Below 6%—Here's The Proof

For the first time since 2022, the average 30-year fixed mortgage rate dipped below the psychological 6% barrier, landing at 5.99% on Friday. This data, reported by Zillow, comes with even better news ...
Wall Street Journal

‘We’re Well Positioned to Wait and See How the Economy Evolves From Here,’ Says Powell

When asked if the Fed is "on hold" for now when it comes to further rate cuts, Fed Chair Jerome Powell told reporters that today’s decision to reduce the benchmark federal-funds rate by a quarter ...
Seeking Alpha

LGRAX Lord Abbett Investment Grade Floating Rate Fund Class A

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
BMJ Open

Effectiveness of brain-computer interface interventions in autism spectrum disorder rehabilitation: a systematic review and meta-analysis protocol

Background Autism spectrum disorder (ASD) is a neurodevelopmental condition characterised by impairments in social ...